PCSK9 Inhibitors: A New Era in Lipid-Lowering Treatment?
Miguel
M
Cainzos-Achirica
Seth S
SS
Martin
John E
JE
Cornell
Cynthia D
CD
Mulrow
Eliseo
E
Guallar
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy*; D008297:Male; D043484:Proprotein Convertases / Q000276:immunology*; D012697:Serine Endopeptidases / Q000276:immunology*
D000911:Antibodies, Monoclonal; D000924:Anticholesteremic Agents; D043484:Proprotein Convertases; D012697:Serine Endopeptidases